“…That communication included 18 relevant references, provided 19 specific technical points, and 6 recommendations, which could be the basis for the ECHO differentiation—between TTS and ACS, or STEMI, and all of them apply to the differentiation between SCAD and TTS. Both conventional 2D and 3D ECHO, and 2D and 3D speckle tracking should be implemented, to unravel whether a patient, shown eventually to have SCAD, has, in addition, a “TTS component,” in the sense that the observed regional RWMA are more extensive and/or involve myocardial territories beyond the one subtended by a coronary artery, or its branches thereof, revealing SCAD (Figures and ) . Patients with subsequently documented SCAD or TTS present with chest pain and are often quickly referred to the catheterization laboratory for diagnosis, which provides information on the coronary arteries, and some insight about the LV chamber (if a uniplane left ventriculogram is carried out, which is not always the case), in terms of showing classic midventricular or apical ballooning, or showing RWMA territorially discordant with the sites perfused by the coronary vessels revealing SCAD.…”